Carmed Pharmaceuticals Founder Mustafa Can Expands Research-Driven Botanicals to the U.S.
Turkey-based science-focused company expands into the United States with standardized carvacrol formulations developed through years of research and structured R&D.
Boca Raton, Florida (Newsworthy.ai) Tuesday Mar 17, 2026 @ 5:00 AM EDT

Mustafa Can, founder of Carmed Pharmaceuticals
“From the beginning, our objective was to approach botanical formulations with scientific discipline.”
Carmed Pharmaceuticals, a science-driven company specializing in standardized carvacrol-based formulations, is expanding into the United States market under the leadership of its founder, Mustafa Can.
The U.S. expansion follows years of research and formulation development led by Can, who established Carmed Pharmaceuticals in 2019 after several years of prior scientific exploration focused on standardized botanical bioactives and mechanism-based product design.
Carmed’s approach integrates traditional botanical knowledge with modern pharmaceutical methodology to create formulations designed to support immune resilience, cellular health, and overall physiological balance.
Founder Vision Behind Carmed Pharmaceuticals
Mustafa Can founded Carmed Pharmaceuticals with the goal of developing scientifically structured botanical formulations built on measurable mechanisms of action and rigorous quality control rather than trend-driven supplement concepts.
Before founding Carmed Pharmaceuticals, Mustafa Can built his career in the maritime industry as a ship master, navigating commercial vessels rather than laboratories. But about a decade ago, a personal fascination with longevity and preventive wellness set him on an unexpected new course. Without formal scientific training, Can immersed himself in an intense period of self-directed study—reviewing thousands of scientific publications and exploring the chemistry of botanical compounds used in traditional medicine. Over time, that curiosity evolved into a focused investigation of standardized, research-driven formulations centered on carvacrol and related bioactive ingredients.
As Carmed grew, that independent research effort expanded into a broader scientific initiative. Today, the company operates with a core team of approximately 25 full-time professionals and collaborates with a broader network of physicians, researchers, laboratories, and medical institutions involved in formulation development and scientific evaluation of bioactive compounds. What began as a personal pursuit of understanding ultimately became the foundation of Carmed Pharmaceuticals and its science-focused approach to botanical formulation development.
“From the beginning, our objective was to approach botanical formulations with scientific discipline,” said Can. “We wanted to focus on standardization, reproducibility, and analytical validation so that formulations are developed with a clear and consistent scientific rationale.”
Can added that Carmed’s long-term strategy prioritizes continued research and product development, with significant resources reinvested into scientific investigation and formulation development.
Today, Carmed operates with a research-driven framework that includes in vitro analysis, mechanism-based evaluation, formulation standardization, and structured quality control processes. All Carmed products are manufactured in facilities operating in accordance with Good Manufacturing Practice (GMP) principles and relevant regulatory standards.
Product Portfolio Entering the U.S.
As part of its U.S. expansion, Carmed Pharmaceuticals plans to introduce several of its flagship formulations:
-
Vacrol® Kids Spray – A carvacrol-based spray formulated to support upper respiratory wellness and microbial balance for children ages 4–11.
-
S-Mix® – A synergy-driven formulation designed to support immune function and healthy cellular activity.
-
Vacrol® Capsule – A standardized carvacrol formulation developed to support microbial balance and immune resilience.
-
Vacrol-M® Capsule – A multi-component botanical formulation designed to support immune function and respiratory wellness.
-
Omevaq-3® – A targeted formulation developed to support cellular energy metabolism and cognitive wellness.
Vacrol® Kids Spray and S-Mix® are gluten-free, non-GMO, sugar-free, preservative-free, and halal-certified.
According to Can, Carmed’s development strategy focuses on combining botanical bioactives in standardized formulations designed to interact across multiple biological pathways.
“Our formulations are built on what we describe as rational synergy,” Can said. “Rather than relying on isolated ingredients, we design standardized combinations selected to work together in a consistent and reproducible manner.”
Scientific Collaboration and Long-Term Positioning
Carmed’s research efforts are supported by collaborations with academic institutions, laboratories, and medical researchers involved in formulation science and bioactive compound evaluation. In January 2026, a study published in the peer-reviewed journal Plants examined Vacrol® and S-Mix® in preclinical laboratory and in ovo models as part of broader scientific investigation into carvacrol-based formulations and multicomponent botanical interactions.
The company emphasizes that such research reflects scientific investigation into botanical bioactivity and formulation design and is not presented as evidence that its consumer products diagnose, treat, cure, or prevent any disease.
As it enters the United States, Carmed states its strategy is focused on regulatory alignment, scientific credibility, and long-term positioning within the preventive wellness sector.
Distribution timelines and retail availability for the United States will be announced in the coming months.
About Carmed Pharmaceuticals
Carmed Pharmaceuticals is a research-driven company specializing in standardized, mechanism-based botanical formulations rooted in Anatolia’s rich botanical heritage. Integrating traditional plant knowledge with modern pharmaceutical technology, Carmed focuses on analytical validation, quality control, and reproducible formulation design.
Officially established in 2019 following years of focused research and development, the company operates with nearly 15 years of industry experience. All products are manufactured in accordance with Good Manufacturing Practice (GMP) principles and relevant regulatory standards, emphasizing safe production, environmental awareness, and continuous quality improvement.
Carmed develops standardized formulations designed to support preventive wellness, immune resilience, and cellular health through science-informed, quality-controlled processes.
Visit Carmed Pharmaceuticals website and visit them on Instagram.
Frequently Asked Questions
- What products is Carmed Pharmaceuticals introducing in the U.S. market?
- Carmed Pharmaceuticals is introducing several flagship formulations in the U.S. market, including Vacrol® Kids Spray, S-Mix®, Vacrol® Capsule, Vacrol-M® Capsule, and Omevaq-3®. These products focus on supporting immune resilience, cellular health, and physiological balance.
- Who is Mustafa Can and what is his role in Carmed Pharmaceuticals?
- Mustafa Can is the founder of Carmed Pharmaceuticals, who transitioned from the maritime industry to the pharmaceutical field. He established the company in 2019 and leads its research-driven approach, focusing on standardized botanical formulations and scientific validation.
- Are there any scientific studies on Carmed Pharmaceuticals' products?
- Yes, a study published in January 2026 in the journal Plants examined Carmed Pharmaceuticals' products Vacrol® and S-Mix® using preclinical laboratory and in ovo models. This highlights the company's commitment to scientific research and validation of their formulations.
